Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:24 PM
Ignite Modification Date:
2025-12-24 @ 12:24 PM
NCT ID:
NCT05578261
Eligibility Criteria:
Inclusion Criteria:
* Adults with autism spectrum disorder (≥18 years old), confirmed by Autism Diagnostic Observation Schedule.
Exclusion Criteria:
* Previous or current severe neurological disorder such as epilepsy, visual or hearing impairment.
* Previous or current severe systemic disease such as cardiovascular disease, diabetes or infection.
* Previous or current severe brain injury
* Implementation of metal materials such as pacemaker or medication pump
* Previous or current severe psychiatric disorders such as schizophrenia, bipolar disorder or substance abuse
* Pregnancy
* Individuals with a significant brain abnormality such as intracranial space occupied lesions
* History of brain surgery or nervous system infection, such as meningitis and encephalitis
* Concurrent use of medications which increased the risk of seizure attack
* Participate another clinical trial within one month
* Skin trauma on application site
* Individuals suffering from multiple sclerosis
* Individuals with a large ischemic scar
* Individuals suffering from sleep deprivation during rTMS procedures
* Individuals with a heavy consumption of alcohol
* Current taking antiepileptic drugs
* Individuals with a migraine headache from increased intracranial pressure
* Unable to complete MRI scan
Withdrawal criteria:
* Seizure attack during study period
* Autistic symptoms worsened obviously during study period
* Extreme agitation or irritability during study period
* Participants request
* Take antiepileptic drug during study period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05578261
Study Brief:
Protocol Section:
NCT05578261